Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Epstein-Barr Virus Infections 2 Cytomegalovirus Infections 2 Colorectal Neoplasms 2 Adenoviridae Infections 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Immunologic Deficiency Syndromes 1 Hodgkin Disease 1 Hematologic Neoplasms 1

Interventions

Temozolomide 393 Radiotherapy 196 Bevacizumab 156 Radiation 77 Magnetic Resonance Spectroscopy 68 Lomustine 47 Surgical Procedures, Operative 42 Carmustine 41 pembrolizumab 39 Irinotecan 38 Nivolumab 32 Specimen Handling 27 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Drug Therapy 21 Cyclophosphamide 20 Aminolevulinic Acid 20 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Vorinostat 13 Sorafenib 13 poly ICLC 12 atezolizumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioblastoma × Cell Count × Clear all

NCT07144735 2025-08-27

ABOUT

Peking University Third Hospital

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡